Items where authors include "Wood, S.L."

Article

Saleh, L., Ottewell, P.D. orcid.org/0000-0002-4826-0771, Brown, J.E. orcid.org/0000-0003-4960-3032 et al. (6 more authors) (2023) The CDK4/6 inhibitor palbociclib inhibits estrogen-positive and triple negative breast cancer bone metastasis in vivo. Cancers, 15 (8). 2211. ISSN 2072-6694

Balan, A. orcid.org/0000-0003-0462-4892, Park, M.A., Wood, S.L. et al. (4 more authors) (2022) A review and comparison of error estimators for anisotropic mesh adaptation for flow simulations. Computers and Fluids, 234. 105259. ISSN 0045-7930

Brown, J.E. orcid.org/0000-0003-4960-3032, Wood, S.L., Confavreux, C. et al. (13 more authors) (2021) Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic : an international perspective and recommendations. Journal of Bone Oncology, 29. 100375. ISSN 2212-1374

Brown, J.E., Westbrook, J.A. and Wood, S.L. (2019) Dedicator of cytokinesis 4 : a potential prognostic and predictive biomarker within the metastatic spread of breast cancer to bone. Cancer Informatics, 18. pp. 1-3.

Westbrook, J.A., Wood, S.L., Cairns, D.A. et al. (14 more authors) (2019) Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer. The Journal of Pathology, 247 (3). pp. 381-391. ISSN 0022-3417

Westbrook, J.A., Cairns, D.A., Peng, J. et al. (10 more authors) (2016) CAPG and gipc1: Breast cancer biomarkers for bone metastasis development and treatment. Journal of the National Cancer Institute, 108 (4). ISSN 0027-8874

Book Section

Wood, S.L., Lopez-Guajardo, A. and Brown, J.E. orcid.org/0000-0003-4960-3032 (2021) Identification of new therapeutic targets of bone cancers by proteomic strategies. In: Heymann, D., (ed.) Bone Sarcomas and Bone Metastases - From Bench to Bedside. Academic Press (Elsevier) , pp. 783-803. ISBN 9780128216668